Education
About Us
Working with TipRanks
Follow Us
AptarGroup, Inc. (DE:AGT)
:AGT
AGT Stock Chart & Stats
Day’s Range― - ―
52-Week Range€111.50 - €166.80
Previous CloseN/A
Volume0.00
Average Volume (3M)31.00
Market Cap
€7.48B
Enterprise Value€11.47B
Total Cash (Recent Filing)€169.76M
Total Debt (Recent Filing)€1.14B
Price to Earnings (P/E)21.3
Beta0.30
Next Earnings
Oct 30, 2025EPS Estimate
1.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.41
Shares Outstanding65,880,520
10 Day Avg. Volume43
30 Day Avg. Volume31
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)4.22
Price to Sales (P/S)2.91
P/FCF Ratio29.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€153.09Price Target Upside35.12% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAptarGroup is evolving into a more pharma-centric packaging company, which has shown strong growth and now constitutes 45% of revenue and nearly 70% of EBITDA.
Market PositionATR is a global leader in Intranasal Drug Delivery Solutions with an estimated market share of over 90%.
ProfitabilityDespite softer revenue growth, AptarGroup has made impressive progress on profitability with 350 basis points of EBITDA margin expansion.
Bears Say
Guidance And ExpectationsThird-quarter EPS guidance came in about 5% below consensus prior to the print.
Legal And Inventory ChallengesLegal expenses related to intellectual property litigation in Pharma are impacting third-quarter guidance.
Pharma Segment ChallengesThe expectation for near-term headwinds in Pharma is anticipated to temporarily nullify its relative advantages compared to other packaging companies.
AptarGroup News
AGT FAQ
What was AptarGroup, Inc.’s price range in the past 12 months?
AptarGroup, Inc. lowest stock price was €111.50 and its highest was €166.80 in the past 12 months.
What is AptarGroup, Inc.’s market cap?
AptarGroup, Inc.’s market cap is €7.48B.
When is AptarGroup, Inc.’s upcoming earnings report date?
AptarGroup, Inc.’s upcoming earnings report date is Oct 30, 2025 which is in 25 days.
How were AptarGroup, Inc.’s earnings last quarter?
AptarGroup, Inc. released its earnings results on Jul 31, 2025. The company reported €1.414 earnings per share for the quarter, beating the consensus estimate of €1.353 by €0.061.
Is AptarGroup, Inc. overvalued?
According to Wall Street analysts AptarGroup, Inc.’s price is currently Undervalued.
Does AptarGroup, Inc. pay dividends?
AptarGroup, Inc. does not currently pay dividends.
What is AptarGroup, Inc.’s EPS estimate?
AptarGroup, Inc.’s EPS estimate is 1.33.
How many shares outstanding does AptarGroup, Inc. have?
AptarGroup, Inc. has 65,880,520 shares outstanding.
What happened to AptarGroup, Inc.’s price movement after its last earnings report?
AptarGroup, Inc. reported an EPS of €1.414 in its last earnings report, beating expectations of €1.353. Following the earnings report the stock price went down -9.891%.
Which hedge fund is a major shareholder of AptarGroup, Inc.?
Currently, no hedge funds are holding shares in DE:AGT
AptarGroup Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€153.09 (35.12% Upside)
€153.09 (35.12% Upside)
Blogger Sentiment
Bullish
DE:AGT Sentiment 70%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $501.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.22%
12-Months-Change
Fundamentals
Return on Equity
15.36%
Trailing 12-Months
Asset Growth
9.25%
Trailing 12-Months
Company Description
AptarGroup, Inc.
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
AGT Company Deck
AGT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a positive picture overall, with strong EPS growth and significant achievements in sustainability and segment performance. However, challenges persist in the Consumer Healthcare segment, Prestige Beauty, and due to increased legal expenses. The normalization of Naloxone sales also presents a potential hurdle.View all DE:AGT earnings summariesAGT Stock 12 Month Forecast
Average Price Target
€153.09
▲(35.12% Upside)
Technical Analysis
Baxter International
―
Cooper Co
―
Repligen
―
West Pharmaceutical Services
―
Stevanato Group
―
Options Prices
Currently, No data available
---